Eric Le Roy, director general of SNITEM (Syndicat National de l’Industrie des Technologies Médicales, The French National Association of the Medical Technologies Industry) discusses the profile of French medtech today, the key trends and challenges its stakeholders are facing, and the top priorities for change he and his members expect to see from health administrators.
The French system today is well positioned to breed many startup companies and can offer plenty of economic help. However, once products obtain their CE mark and are manufactured in France, the current environment makes introducing the device in the country nearly impossible for a small innovation-driven company
